184 related articles for article (PubMed ID: 7051248)
21. Intravenous sulfamethoxazole-trimethoprim: pharmacokinetics, therapeutic indications, and adverse reactions.
Gleckman R; Gantz NM; Joubert DW
Pharmacotherapy; 1981; 1(3):206-11. PubMed ID: 6985449
[TBL] [Abstract][Full Text] [Related]
22. Empiric antimicrobial therapy in febrile granulocytopenic patients. Randomized prospective comparison of amikacin plus piperacillin with or without parenteral trimethoprim/sulphamethoxazole.
Menichetti F; Del Favero A; Guerciolini R; Tonato M; Aversa F; Roila F; Frongillo RF; Martelli MF; Davis S; Pauluzzi S
Infection; 1986; 14(6):261-7. PubMed ID: 3546144
[TBL] [Abstract][Full Text] [Related]
23. Relative efficacy of carbenicillin indanyl sodium and of trimethoprim/sulfamethoxazole in urinary-tract infections.
Seneca H
J Am Geriatr Soc; 1979 May; 27(5):222-4. PubMed ID: 581878
[TBL] [Abstract][Full Text] [Related]
24. Ceftazidime with or without vancomycin vs. cephalothin, carbenicillin and gentamicin as the initial therapy of the febrile neutropenic pediatric cancer patient.
Granowetter L; Wells H; Lange BJ
Pediatr Infect Dis J; 1988 Mar; 7(3):165-70. PubMed ID: 3282214
[TBL] [Abstract][Full Text] [Related]
25. Trimethoprim-sulfamethoxazole.
Hughes WT
Pediatr Clin North Am; 1983 Feb; 30(1):27-30. PubMed ID: 6600834
[No Abstract] [Full Text] [Related]
26. In vitro models for the study of combination antibiotic therapy in neutropenic patients.
Zinner SH; Dudley M; Blaser J
Am J Med; 1986 Jun; 80(6B):156-60. PubMed ID: 3728526
[TBL] [Abstract][Full Text] [Related]
27. Beta-lactam antibiotics alone or in combination with gentamicin for therapy of gram-negative bacillary infections in neutropenic patients.
Bodey GP; Feld R; Burgess MA
Am J Med Sci; 1976; 271(2):179-86. PubMed ID: 773180
[TBL] [Abstract][Full Text] [Related]
28. Potential role of trimethoprim-sulfamethoxazole in the treatment of serious hospital-acquired bacterial infections.
Quintiliani R; Levitz RE; Nightingale CH
Rev Infect Dis; 1987; 9 Suppl 2():S160-7. PubMed ID: 3554454
[TBL] [Abstract][Full Text] [Related]
29. Prophylactic co-trimoxazole versus norfloxacin in neutropenic children--perspective randomized study.
Cruciani M; Concia E; Navarra A; Perversi L; Bonetti F; Aricò M; Nespoli L
Infection; 1989; 17(2):65-9. PubMed ID: 2654019
[TBL] [Abstract][Full Text] [Related]
30. Trimethoprim-sulfamethoxazole in the treatment of adults with pneumonia due to Pneumocystis carinii.
Young LS
Rev Infect Dis; 1982; 4(2):608-13. PubMed ID: 6981177
[TBL] [Abstract][Full Text] [Related]
31. Oral trimethoprim/sulfamethoxazole for prevention of bacterial infection during the induction phase of cancer chemotherapy in children.
Kovatch AL; Wald ER; Albo VC; Prin W; Orlando SJ; Wollman MR; Phebus CK; Shapiro ED
Pediatrics; 1985 Nov; 76(5):754-60. PubMed ID: 3903647
[TBL] [Abstract][Full Text] [Related]
32. Empirical antibiotic therapy in febrile patients with neutropenia and malignant disease.
Tattersall MH; Hutchinson RM; Gaya H; Spiers AS
Eur J Cancer (1965); 1973 Jun; 9(6):417-23. PubMed ID: 4372049
[No Abstract] [Full Text] [Related]
33. Use of trimethoprim-sulfamethoxazole in pediatric infections: relative merits of intravenous administration.
Overturf GD
Rev Infect Dis; 1987; 9 Suppl 2():S168-76. PubMed ID: 3554455
[TBL] [Abstract][Full Text] [Related]
34. [Prophylactic controlled trials with cotrimoxazole in afebrile neutropenic patients with malignant hemopathies].
Scaglione C; Tormena AM; Pavlovsky S
Sangre (Barc); 1982; 27(5):912-8. PubMed ID: 6820192
[No Abstract] [Full Text] [Related]
35. Treatment of experimentally induced enterotoxigenic Escherichia coli diarrhea with trimethoprim, trimethoprim-sulfamethoxazole, or placebo.
Black RE; Levine MM; Clements ML; Cisneros L; Daya V
Rev Infect Dis; 1982; 4(2):540-5. PubMed ID: 7051247
[TBL] [Abstract][Full Text] [Related]
36. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis.
Fox BC; Sollinger HW; Belzer FO; Maki DG
Am J Med; 1990 Sep; 89(3):255-74. PubMed ID: 2118307
[TBL] [Abstract][Full Text] [Related]
37. Double-blind comparison of sulphonamide-trimethoprim combinations in acute uncomplicated urinary tract infections.
Skjerven O; Bergan T
Infection; 1979; 7 Suppl 4():S398-400. PubMed ID: 389813
[TBL] [Abstract][Full Text] [Related]
38. Neutropenia induced by short-term oral trimethoprim-sulfamethoxazole therapy; case report.
Harris GJ; Franson TR
Wis Med J; 1986 Mar; 85(3):19-21. PubMed ID: 3486531
[No Abstract] [Full Text] [Related]
39. Indications for systemic antibiotic prophylaxis in neutropenic patients.
Spiers AS; Tattersall MH; Gaya H
Br Med J; 1974 Nov; 4(5942):440-1. PubMed ID: 4214579
[TBL] [Abstract][Full Text] [Related]
40. Synergistic activity of carbenicillin and gentamicin in experimental Pseudomonas bacteremia in neutropenic rats.
Scott RE; Robson HG
Antimicrob Agents Chemother; 1976 Oct; 10(4):646-51. PubMed ID: 825035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
